Irritable Bowel Syndrome

VANCOUVER, British Columbia — ChatGPT 4.0 had an overall accuracy of 80% in its answers to questions about irritable bowel syndrome, although the chatbot still missed some details or provided outdated information, according to research.

VANCOUVER, British Columbia — Continued Ibsrela therapy for 12 weeks enabled early nonresponders with irritable bowel syndrome and constipation to achieve a meaningful response, noted a presenter at the ACG Annual Scientific Meeting.

For more than 4 years, the Healio podcast, Gut Talk, has provided busy clinicians with relevant insights and updates on research developments through interviews and candid conversations with leaders of the gastroenterology field.

In this Healio exclusive video, Anita Afzali, MD, previews the upcoming 2023 ACG Annual Scientific Meeting, which will feature a variety of “hot topics,” including the impact of virtual reality and artificial intelligence on practice today.

Case-control and cohort analyses showed dysphasia, gastroparesis, irritable bowel syndrome without diarrhea and constipation may be associated with an increased risk for Parkinson’s disease, according to research in Gut.

A nationwide survey of nearly 89,000 individuals estimated the prevalence of Rome IV irritable bowel syndrome in the U.S. to be 6.1% compared with 4.7% to 5.3% in previous reports, according to a cross-sectional study in Gastroenterology.

In this month’s issue, we are highlighting the important topic of multidisciplinary care of our gastroenterology patients.

What the poet John Donne observed about humanity — “no man is an island, entire of itself; every man is a piece of the continent, a part of the main” — holds true for health care providers. No provider operates in a vacuum; no provider stands alone.

In a Healio video exclusive, Austin Chiang, MD, MPH, discusses an annual TikTok trend, “No Poop July,” and warns of the potentially harmful effects of participating in this type of fake, health-related challenge.

From the impact of Humira biosimilars flooding the U.S. market to shifting trends in colorectal cancer demographics, Healio has asked experts the big questions to stay abreast of the current hot topics in gastroenterology and hepatology.